Form EFFECT NAVIDEA BIOPHARMACEUTICA

May 25, 2022 6:06 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 24, 2022
Accession Number: 0001437749-22-012862
Submission Type: POS AM
CIK: 0000810509
Company Name: NAVIDEA BIOPHARMACEUTICALS, INC.
File Number: 333-184173


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings